Skip to content

Clinical trials

Completed Hyperlipidemias trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Status: Completed Country / region: Germany Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20053
20062
20071
20081
20091
20101
20111
20121
20136
20161
20171
20181
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen5
Takeda4
AstraZeneca2
Pfizer2
Solvay Pharmaceuticals2
89bio, Inc.1
Akcea Therapeutics1
Bayer1
Eli Lilly and Company1
Esperion Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias27
Hypercholesterolemia9
Dyslipidemias6
Diabetes Mellitus5
Diabetes Mellitus, Type 23
Atherosclerosis2
Cardiovascular Diseases2
Coronary Disease2
Hypertension2
Coronary Artery Disease1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.